Michael Rudolph to Tamoxifen
This is a "connection" page, showing publications Michael Rudolph has written about Tamoxifen.
Connection Strength
0.099
-
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.
Score: 0.060
-
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. 2018 07 26; 3(14).
Score: 0.038